Infinion Biopharma
Ticker > Company >

Infinion Biopharma share price

Infinion Biopharma Ltd.

SECTOR: Pharmaceuticals & Drugs  2199   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 Year574.37%
3 YearNA
5 YearNA

ROE%

1 Year51.26%
3 Year11.18%

ROCE %

1 Year50.67%
3 Year11.23%

Debt/Equity

0

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has significantly decreased its debt by 0.299672 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 16.1643555685301.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021
Net Sales 0 0 0
Total Expenditure 0 1.37 0.41
Operating Profit 0 -1.37 -0.41
Other Income 0 0 6.9
Interest 0 0 0
Depreciation 0 0 0
Exceptional Items 0 0 0
Profit Before Tax 0 -1.37 6.49
Tax 0 0 0
Net Profit 0 -1.37 6.49
Adjusted EPS (Rs.) 0 -1.37 6.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 7.55 9.99 10.45
Total Reserves -0.36 -1.73 6.59
Borrowings 0.37 0.3 0
Other N/C liabilities 0 0 0
Current liabilities 0.03 0.13 0.06
Total Liabilities 7.58 8.69 17.11
Assets
Net Block 0 0 0.01
Capital WIP 0 0 0
Intangible WIP 0 0 0
Investments 0 0.02 16.1
Loans & Advances 0 0 0
Other N/C Assets 0 0 0
Current Assets 7.58 8.66 1
Total Assets 7.58 8.69 17.11
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021
Profit from operations -1.37 6.49
Adjustment 0.21 -6.7
Changes in Assets & Liabilities -0.3 7.74
Tax Paid 0 0
Operating Cash Flow -1.46 7.52
Investing Cash Flow -0.02 -9.38
Financing Cash Flow 1.44 2
Net Cash Flow -0.05 0.13

Corporate Actions

Last Updated on:
Brief about Infinion Biopharma
X